LIU Andy 劉安庭

Mr. Andy Liu

  • President Healthcare and International, BaseBit Technologies
  • Board of Directors, ASTRI
  • Vice Chairman, HKBIO
  • Healthcare Advisor, InvestHK

Mr. Andy A. Liu is currently the President for Healthcare and International at Basebit Technologies.

Mr. Liu’s area of focus is big data, AI and digital solutions specifically in the Healthcare Sector. Previously, Mr. Liu is the CEO of CW Data Technologies and CEO of Ilumi Health.

Mr. Liu also served as the President of Asia Pacific and China for IQVIA. (Previously known as IMS Health) which is a global leader in healthcare data analytics. Mr. Liu managed the Data Analytics, Digital Solutions, and Commerical and Consulting businesses for the entire Asia Pacific. Mr. Liu was responsible for managing the P&L of the entire region inclusive of 17 countries including China, Australia, India, South Korea, New Zealand, Hong Kong, Taiwan, Vietnam, Indonesia, Philippines, Thailand, Singapore, Malaysia, Taiwan, Bangladesh, Sri Lanka and Pakistan.

Mr. Liu has spent many years with multinational companies such as Merck and UCB Pharma holding several executive management and leadership positions in the USA and Asia. Mr. Liu has also spent many years with private equity firm TPG as an operator running TPG portfolio companies including IMS and Moksha8.

He also has extensive experience in product launch and commercialization: inclusive of regulatory approval, pricing, customer acquisition, marketing and sales execution. He has successfully managed and launched products across key therapeutic franchises such as hypertension, atherosclerosis, anticonvulsants, arthritis, antihistamine, osteoporosis and diabetes. He also has strong experience in deal transactions, investments, joint ventures and mergers and acquisitions in the life sciences sector.